Ludwig Enterprises (LUDG) Net Income towards Common Stockholders (2022 - 2026)

Ludwig Enterprises (LUDG) posted Net Income towards Common Stockholders of $218847.0 for Q1 2026, up 120.31% on a QoQ basis from -$1.1 million in Q4 2025, and up 140.46% year-over-year from $91013.1 in Q1 2025.

Ludwig Enterprises (LUDG) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

Ludwig Enterprises' Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at $218847.0 for Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 140.46% year-over-year to $218847.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 35.98% YoY) and the FY2025 annual result came in at -$2.2 million, down 6525.98% from the prior year.
  • Net Income towards Common Stockholders was $218847.0 for Q1 2026 at Ludwig Enterprises, up from -$1.1 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $245833.0 in Q4 2024 and bottomed at -$1.1 million in Q4 2025.
  • A 5-year average of -$374817.3 and a median of -$456322.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders surged 166.14% — and 2025, when it sank 1562.6%.
  • Ludwig Enterprises' Net Income towards Common Stockholders stood at -$681105.0 in 2022, then jumped by 45.43% to -$371701.0 in 2023, then jumped by 166.14% to $245833.0 in 2024, then slumped by 538.22% to -$1.1 million in 2025, then surged by 120.31% to $218847.0 in 2026.
  • Business Quant data shows LUDG's Net Income towards Common Stockholders at $218847.0 in Q1 2026, -$1.1 million in Q4 2025, and $31252.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Ludwig Enterprises 3.27 Mn 3.27 Mn - 218,847.00

Historic Data

Download Data
DateValue
Mar 31, 2026 218,847.00
Dec 31, 2025 -1.08 Mn
Sep 30, 2025 31,252.00
Jun 30, 2025 -649,444.00
Mar 31, 2025 -540,943.00
Dec 31, 2024 245,833.00
Sep 30, 2024 -749,129.00
Jun 30, 2024 -41,681.00
Mar 31, 2024 -32,536.00
Dec 31, 2023 -371,701.00
Sep 30, 2023 -195,570.00
Jun 30, 2023 -583,447.00
Mar 31, 2023 -820,520.00
Dec 31, 2022 -681,105.00